These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 26687550
1. Assessment of hypertension control and clinical course of patients excluded from the SYMPLICITY HTN-3 trial. Yerasi C, Baker NC, Jonnalagadda AK, Torguson R, Singh S, Vies J, Waksman R. J Am Soc Hypertens; 2015 Dec; 9(12):959-65. PubMed ID: 26687550 [Abstract] [Full Text] [Related]
10. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs. Mauri L, Kario K, Basile J, Daemen J, Davies J, Kirtane AJ, Mahfoud F, Schmieder RE, Weber M, Nanto S, Azizi M. Am Heart J; 2018 Jan; 195():115-129. PubMed ID: 29224639 [Abstract] [Full Text] [Related]
11. SYMPLICITY HTN-Japan - First Randomized Controlled Trial of Catheter-Based Renal Denervation in Asian Patients - . Kario K, Ogawa H, Okumura K, Okura T, Saito S, Ueno T, Haskin R, Negoita M, Shimada K, SYMPLICITY HTN-Japan Investigators. Circ J; 2015 Jan; 79(6):1222-9. PubMed ID: 25912693 [Abstract] [Full Text] [Related]
12. High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3. Waksman R, Bakris GL, Steinvil A, Garcia-Garcia H, Brown AL, DiFilippo W, Scott T, Singh J, DeBruin V, Jones D, Jolivette D, Bhatt DL. Am Heart J; 2017 Oct; 192():76-84. PubMed ID: 28938966 [Abstract] [Full Text] [Related]
13. The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension. Weber MA, Kirtane AJ, Weir MR, Radhakrishnan J, Das T, Berk M, Mendelsohn F, Bouchard A, Larrain G, Haase M, Diaz-Cartelle J, Leon MB. JACC Cardiovasc Interv; 2020 Feb 24; 13(4):461-470. PubMed ID: 32081240 [Abstract] [Full Text] [Related]
16. Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatients. Hayek SS, Abdou MH, Demoss BD, Legaspi JM, Veledar E, Deka A, Krishnan SK, Wilmot KA, Patel AD, Kumar VR, Devireddy CM. Am J Hypertens; 2013 Dec 24; 26(12):1452-8. PubMed ID: 23934709 [Abstract] [Full Text] [Related]
17. [Renal denervation a treatment for resistant hypertension: a French experience]. Benamer H, Mylotte D, Garcia-Alonso C, Unterseeh T, Garot P, Louvard Y, Lefevre T, Morice MC, ICV-GVM la Roseraie. Ann Cardiol Angeiol (Paris); 2013 Dec 24; 62(6):384-91. PubMed ID: 24182849 [Abstract] [Full Text] [Related]
18. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial. Esler MD, Böhm M, Sievert H, Rump CL, Schmieder RE, Krum H, Mahfoud F, Schlaich MP. Eur Heart J; 2014 Jul 24; 35(26):1752-9. PubMed ID: 24898552 [Abstract] [Full Text] [Related]
19. Renal denervation in moderate treatment-resistant hypertension. Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE. J Am Coll Cardiol; 2013 Nov 12; 62(20):1880-6. PubMed ID: 23850901 [Abstract] [Full Text] [Related]
20. A Systematic Review of Randomized Controlled Trials Comparing Renal Sympathetic Denervation Versus Sham Procedure for the Management of Uncontrolled Hypertension. Maqsood MH, Rubab K, Anwar F, Afzal Khan MT, Maqsood MA, Farooq M, Tabaza L, Rangaswami J, Virk HUH. J Cardiovasc Pharmacol; 2021 Feb 01; 77(2):153-158. PubMed ID: 33235031 [Abstract] [Full Text] [Related] Page: [Next] [New Search]